Source: DGNews  |  Posted 8 years ago

By Rabiya S. Tuma

CHICAGO, IL -- June 3, 2003 -- Sequential treatment with doxorubicin and docetaxel is as effective as concurrent therapy in patients with metastatic breast cancer, but is significantly less toxic, according to results presented here June 1st at the 39th Annual Meeting of the American Society of Clinical Oncology.

The combination of doxorubicin and docetaxel has good efficacy but its use is limited by the febrile neutropenia associated with this regimen, said Emilio Alba, MD, from the Hospital Virgen de la Victoria, in M